logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9353091 B1

PDFFull Text
Date of Patent:
May. 31, 2016

Filed:

Apr. 24, 2014

Antiviral compounds and uses thereof

Applicant:

Abbvie Inc., North Chicago, IL (US);

Inventors:

David A. Betebenner, Grayslake, IL (US);

John K. Pratt, Kenosha, WI (US);

David A. DeGoey, Salem, WI (US);

Pamela L. Donner, Mundelein, IL (US);

Charles A. Flentge, Salem, WI (US);

Douglas K. Hutchinson, Newtown, CT (US);

Warren M. Kati, Gurnee, IL (US);

Allan C. Krueger, Gurnee, IL (US);

Kenton L. Longenecker, Grayslake, IL (US);

Clarence J. Maring, Palatine, IL (US);

John T. Randolph, Libertyville, IL (US);

Todd W. Rockway, Gurnee, IL (US);

Michael D. Tufano, Chicago, IL (US);

Rolf Wagner, Antioch, IL (US);

Dachun Liu, Vernon Hills, IL (US);

Assignee:

ABBVIE INC., North Chicago, IL (US);

Attorneys:

Neal, Gerber & Eisenberg LLP

Kevin A. O'Connor

Primary Examiner:

Alexander R Pagano

Int. Cl.
CPC ...
A61K 31/503 (2006.01); C07D 409/10 (2006.01); C07C 311/08 (2006.01); C07D 207/27 (2006.01); C07D 213/64 (2006.01); C07D 233/32 (2006.01); C07D 233/72 (2006.01); C07D 239/10 (2006.01); C07D 239/54 (2006.01); C07D 263/22 (2006.01); C07D 275/02 (2006.01); C07D 403/10 (2006.01); C07D 405/10 (2006.01); A61K 31/18 (2006.01); A61K 31/27 (2006.01); A61K 31/4166 (2006.01); A61K 31/421 (2006.01); A61K 31/4418 (2006.01); A61K 31/513 (2006.01); A61K 45/06 (2006.01); C07D 263/24 (2006.01);
U.S. Cl.
CPC ...
C07D 409/10 (2013.01); A61K 31/18 (2013.01); A61K 31/27 (2013.01); A61K 31/4166 (2013.01); A61K 31/421 (2013.01); A61K 31/4418 (2013.01); A61K 31/503 (2013.01); A61K 31/513 (2013.01); A61K 45/06 (2013.01); C07C 311/08 (2013.01); C07D 207/27 (2013.01); C07D 213/64 (2013.01); C07D 233/32 (2013.01); C07D 233/72 (2013.01); C07D 239/10 (2013.01); C07D 239/54 (2013.01); C07D 263/22 (2013.01); C07D 263/24 (2013.01); C07D 275/02 (2013.01); C07D 403/10 (2013.01); C07D 405/10 (2013.01);
Abstract

This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

Find Patent Forward Citations

Loading…